BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schieferdecker A, Oberle A, Thiele B, Hofmann F, Göthel M, Miethe S, Hust M, Braig F, Voigt M, von Pein U, Koch-nolte F, Haag F, Alawi M, Indenbirken D, Grundhoff A, Bokemeyer C, Bacher U, Kröger N, Binder M. A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma. Blood 2016;127:3202-14. [DOI: 10.1182/blood-2015-10-676536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Klausz K, Cieker M, Kellner C, Oberg HH, Kabelitz D, Valerius T, Burger R, Gramatzki M, Peipp M. A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries. Oncotarget 2017;8:77552-66. [PMID: 29100408 DOI: 10.18632/oncotarget.20641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Qiang X, Sun K, Xing L, Xu Y, Wang H, Zhou Z, Zhang J, Zhang F, Caliskan B, Wang M, Qiu Z. Discovery of a polystyrene binding peptide isolated from phage display library and its application in peptide immobilization. Sci Rep 2017;7:2673. [PMID: 28572662 DOI: 10.1038/s41598-017-02891-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
3 Garfall AL, Stadtmauer EA. Cellular and vaccine immunotherapy for multiple myeloma. Hematology Am Soc Hematol Educ Program 2016;2016:521-7. [PMID: 27913524 DOI: 10.1182/asheducation-2016.1.521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
4 Rasche L, Weinhold N, Morgan GJ, van Rhee F, Davies FE. Immunologic approaches for the treatment of multiple myeloma. Cancer Treat Rev 2017;55:190-9. [PMID: 28431262 DOI: 10.1016/j.ctrv.2017.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
5 Carvalho GB, Costa LE, Lage DP, Ramos FF, Santos TTO, Ribeiro PAF, Dias DS, Salles BCS, Lima MP, Carvalho LM, Dias ACS, Alves PT, Franklin ML, Silva RAM, Duarte MC, Menezes-Souza D, Roatt BM, Chávez-Fumagalli MA, Goulart LR, Teixeira AL, Coelho EAF. High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection. Parasitology 2019;146:322-32. [PMID: 30198459 DOI: 10.1017/S0031182018001403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]